Krystal Biotech, Inc. KRYS
What the 10-K filed Feb 17, 2026 says off the balance sheet
10-K notesRisks that are not on the face of the balance sheet. Tickdelta picks sentences with specifics and quotes them as filed. New marks a sentence with nothing like it in the 10-K filed Feb 19, 2025.
Big customers
Customers the company names as a large share of revenue or receivables (it must name any worth 10% of revenue).
“For the years ended December 31, 2025, 2024, and 2023, approximately 75%, 87% and 100%, respectively, of the Company’s product revenue, net was generated from a single customer in the U.S.”
75% in the 10-K filed 2026-02-17, 87% in the one filed 2025-02-19
Read it in the 10-K
“Net product revenue receivable from the Company’s customers who individually accounted for 10% or more of net product revenue receivable consisted of the following:”
10% in the 10-K filed 2026-02-17, 10% in the one filed 2025-02-19
Read it in the 10-K
Key suppliers
Parts or manufacturing that depend on one or a few suppliers.
“In relevant part, the IRA allows Medicare to negotiate prices for certain prescription drugs, requires drug manufacturers to pay a rebate to the federal government if prices for single-source drugs and biologicals covered under Medicare Part B and nearly all covered drugs under Part D increase faster than the rate of inflation, caps out of pocket spending for Medicare Part D enrollees, and makes other benefit design changes to Medicare Part D intended to lower drug costs for enrollees and Medicare.”
Read it in the 10-K
“Our use of a limited number of suppliers for some of the components and materials used in manufacturing VYJUVEK and our product candidates and commercially supplying VYJUVEK exposes us to several risks, including disruptions in supply, price increases, late deliveries, and an inability to meet demand.”
Read it in the 10-K
“be unable to meet our production demands due to issues related to their reliance on sole-source suppliers and manufacturers;”
Read it in the 10-K
“Because we do not anticipate paying any cash dividends on our common stock in the foreseeable future, capital appreciation, if any, will be stockholders’ sole source of gain.”
Read it in the 10-K
Lawsuits and legal claims
Pending cases, settlements and what the company has set aside for them.
“Litigation settlement for the years ended December 31, 2025, 2024 and 2023 was zero, $37.5 million and $12.5 million, respectively, and consisted of amounts related to the settlement of litigation with PeriphaGen.”
Read it in the 10-K
“In exchange for an upfront payment of $25.0 million and four contingent milestone payments of $12.5 million each, PeriphaGen (i) released all claims in the litigation; (ii) transferred certain assets to the Company and (iii) granted the Company a license for dermatological applications.”
Read it in the 10-K
New “During the year ended December 31, 2025, the Company paid $31.25 million, and together with the $43.75 million paid prior to 2025, has fully paid the $75.0 million of total consideration in connection with the settlement of the PeriphaGen litigation.”
Read it in the 10-K
“The Company recorded litigation settlement expense for the contingent milestone payments of zero, $37.5 million and $12.5 million for the years ended December 31, 2025, 2024, and 2023, respectively, on the consolidated statements of operations and comprehensive income.”
Read it in the 10-K
New “The parties have reached an agreement in principle on settlement terms but must still negotiate and execute a definitive settlement agreement, which will be filed with the Delaware Court of Chancery and is subject to court approval.”
Read it in the 10-K
Guarantees and indemnities
Promises to pay someone else's debts or losses if they cannot.
No specific sentence about this in the 10-K.
Debt covenants
Conditions in loan agreements that, if broken, can make debt due early.
No specific sentence about this in the 10-K.
Commitments off the balance sheet
Contracts the company must pay for later: purchase obligations, take-or-pay deals.
No specific sentence about this in the 10-K.
Companies it names
Tracked companies that its latest 10-K or its 8-Ks of the last year call a customer or a supplier.
No other tracked company is named as a customer or a supplier in the latest filings.
Companies that name it
Tracked companies whose latest 10-K or 8-Ks call it a customer or a supplier.
No other tracked company names it as a customer or a supplier in the latest filings.
Sentences are chosen by their words, not read by AI, so some can be off topic. Always check the filing. Open the 10-K
Sources
The notes to the financial statements, Legal Proceedings and the MD&A of the latest 10-K (and, for customers and suppliers, Business and Risk Factors), quoted as filed.
Also
Debt: the debt note in numbers.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/KRYS/export.csv") into a cell.